Left ventricular noncompaction cardiomyopathy in end-stage heart failure patients undergoing orthotopic heart

Giulia Ottaviani1, Ana Maria Segura2, Indranee N Rajapreyar3

  • 1Department of Pathology and Laboratory Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA; "Lino Rossi" Research Center for the study and prevention of unexpected perinatal death and sudden infant death syndrome (SIDS)-Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.

Insights

Left ventricular noncompaction (LVNC) is an uncommon cause of end-stage heart failure in heart transplant recipients, primarily seen in nonischemic cardiomyopathy. Further research is needed to clarify diagnostic criteria for LVNC.

Area of Science:

  • Cardiology
  • Pathology
  • Genetics

Background:

  • Left ventricular noncompaction (LVNC) is a cardiomyopathy resulting from abnormal embryonic development of heart trabeculae.
  • Diagnosis is typically by echocardiography, but its prevalence and pathological features in heart transplant explants are understudied.

Purpose of the Study:

  • To investigate the occurrence and clinicopathological characteristics of LVNC in explanted hearts from orthotopic heart transplant (OHT) recipients.
  • To compare echocardiographic and pathological findings for LVNC diagnosis.

Main Methods:

  • Reviewed clinical, echocardiographic, and pathological data from 105 end-stage heart failure patients undergoing OHT.
  • Assessed explanted hearts for LVNC, grading myocardial fibrosis, hypertrophy, and myocytolysis.
  • Calculated measurements of noncompacted and compacted left ventricular walls and their ratio.

Main Results:

  • LVNC was identified in 7.8% of nonischemic cardiomyopathy patients (4/51), but none with ischemic cardiomyopathy.
  • Echocardiograms showed severe left ventricular dilatation, prominent trabeculations, and low ejection fraction (<20%).
  • Pathological analysis revealed significant noncompacted myocardium (22±5.8mm) with a high noncompacted/compacted ratio (1.7/1).

Conclusions:

  • LVNC is an infrequent cause of nonischemic cardiomyopathy leading to OHT.
  • Variability in noncompacted/compacted ratios and discordance between imaging and pathology highlight the need for refined diagnostic criteria.
  • Larger studies correlating clinical, anatomical, and genetic factors are essential for understanding LVNC's role in advanced heart failure.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
605
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
733
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
643
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
755
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
775
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
418